JP2025505632A5 - - Google Patents
Info
- Publication number
- JP2025505632A5 JP2025505632A5 JP2024546294A JP2024546294A JP2025505632A5 JP 2025505632 A5 JP2025505632 A5 JP 2025505632A5 JP 2024546294 A JP2024546294 A JP 2024546294A JP 2024546294 A JP2024546294 A JP 2024546294A JP 2025505632 A5 JP2025505632 A5 JP 2025505632A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- subject
- approximately
- composition according
- reduction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263307470P | 2022-02-07 | 2022-02-07 | |
| US63/307,470 | 2022-02-07 | ||
| US202263382426P | 2022-11-04 | 2022-11-04 | |
| US63/382,426 | 2022-11-04 | ||
| PCT/US2023/062065 WO2023150759A1 (en) | 2022-02-07 | 2023-02-06 | Methods of weight loss in a subject with elevated hba1c |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025505632A JP2025505632A (ja) | 2025-02-28 |
| JP2025505632A5 true JP2025505632A5 (https=) | 2026-02-16 |
Family
ID=85569618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024546294A Pending JP2025505632A (ja) | 2022-02-07 | 2023-02-06 | 上昇したＨｂＡ１ｃを有する対象における体重減少の方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250134865A1 (https=) |
| EP (1) | EP4475842A1 (https=) |
| JP (1) | JP2025505632A (https=) |
| KR (1) | KR20240146053A (https=) |
| AU (1) | AU2023214495A1 (https=) |
| CA (1) | CA3243643A1 (https=) |
| IL (1) | IL314682A (https=) |
| MX (1) | MX2024009644A (https=) |
| WO (1) | WO2023150759A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018129258A1 (en) | 2017-01-06 | 2018-07-12 | Gencia Corporation | Novel phenyl derivatives |
| EP4340829A1 (en) * | 2021-05-20 | 2024-03-27 | Rivus Pharmaceuticals, Inc. | Methods of treating mitochondria-related disorders |
-
2023
- 2023-02-06 CA CA3243643A patent/CA3243643A1/en active Pending
- 2023-02-06 IL IL314682A patent/IL314682A/en unknown
- 2023-02-06 WO PCT/US2023/062065 patent/WO2023150759A1/en not_active Ceased
- 2023-02-06 KR KR1020247029814A patent/KR20240146053A/ko active Pending
- 2023-02-06 MX MX2024009644A patent/MX2024009644A/es unknown
- 2023-02-06 JP JP2024546294A patent/JP2025505632A/ja active Pending
- 2023-02-06 US US18/835,578 patent/US20250134865A1/en active Pending
- 2023-02-06 AU AU2023214495A patent/AU2023214495A1/en active Pending
- 2023-02-06 EP EP23710591.1A patent/EP4475842A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8071557B2 (en) | Treatment of pulmonary hypertension with carbonic anhydrase inhibitors | |
| Auvinet et al. | Comparison of the onset and intensity of action of intramuscular meloxicam and oral meloxicam in patients in acute sciatica | |
| AU2014211628B2 (en) | Compositions comprising 15-OHEPA and methods of using the same | |
| JP2018514534A5 (https=) | ||
| JP2001509173A (ja) | 胃腸リパーゼ阻害剤の使用 | |
| EP3226873B1 (en) | Compositions comprising 15-hepe and its use for treating or preventing idiopathic pulomonary fibrosis | |
| JP2020504129A (ja) | 非アルコール性脂肪性肝炎（ｎａｓｈ）および肝線維症のための併用療法 | |
| JP2025505187A5 (https=) | ||
| WO2022042541A1 (zh) | 眼镜蛇蛇毒或其提取物在制备降尿酸和/或抗痛风性关节炎的药物中的应用 | |
| JP2024532957A5 (https=) | ||
| JP2025505632A5 (https=) | ||
| JP2002512191A (ja) | Ｌ−カルニチンまたはアルカノイルｌ−カルニチンおよびｎａｄｈおよび／またはｈａｄｐｈを含む組成物。 | |
| WO2018163119A1 (en) | 1-piperidinepropionic acid for treating a fibrosing disease | |
| JP4355967B2 (ja) | 医薬組成物 | |
| JP7549405B2 (ja) | 鎮痛・鎮痒医薬組成物及びその使用方法 | |
| CN112972440B (zh) | 麝香酮在制备防治抑郁症的药物中的用途 | |
| van der Woude et al. | Long-acting β2-agonists: comparative pharmacology and clinical outcomes | |
| WO2013170711A1 (zh) | 一种用于镇痛的药物组合产品 | |
| TWI544928B (zh) | 麥角固醇於製造藥劑之用途 | |
| JP5452042B2 (ja) | 医薬組成物 | |
| WO2019224602A2 (en) | Structurally modified fatty acids for improving glycemic control and treating inflammatory bowel disease | |
| CN102614382A (zh) | 一种用于治疗帕金森病的中药组合物及制备方法和用途 | |
| CN116712420A (zh) | 一种花椒酰胺在制备治疗多发性硬化症的药物中的应用 | |
| KR20240146053A (ko) | 상승된 HbA1c를 갖는 대상체에서의 체중 감소 방법 | |
| WO2014171740A1 (ko) | 아세클로페낙 또는 이의 약학적으로 허용 가능한 염과 위령선, 천화분 및 하고초를 포함하는 추출물을 포함하는 관절염의 치료 또는 개선용 약학 조성물 |